Logo-bi
Review

1. Impacts of Nanomedicines in Ocular Pharmacotherapy
Ailar Nakhlband, Jaleh Barar* ORCID
Bioimpacts. 2011;1(1): 7-22. doi: 10.5681/bi.2011.003
PMCID: PMC3648943     PMID: 23678403     Scopus ID: 84876715577    
Article
PDF
XML
Cited By:
16
7
0
Review

2. Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy
Sanjay Singh*
Bioimpacts. 2013;3(2): 53-65. doi: 10.5681/bi.2013.007
PMCID: PMC3713871     PMID: 23878788     Scopus ID: 84881502609    
Article
PDF
XML
Cited By:
38
7
0
Editorial

3. Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy
S. Moein Moghimi*, Fatemeh Rahbarizadeh, Davoud Ahmadvand, Ladan Parhamifar
Bioimpacts. 2013;3(1): 1-4. doi: 10.5681/bi.2013.009
PMCID: PMC3648910     PMID: 23678463     Scopus ID: 84879192201    
Article
PDF
XML
Cited By:
16
7
0
Editorial

4. The challenges of green nanotechnology
Miguel de la Guardia*
Bioimpacts. 2014;4(1): 1-2. doi: 10.5681/bi.2014.009
PMCID: PMC4005277     PMID: 24790892     Scopus ID: 84900478943    
Article
PDF
XML
Cited By:
10
3
0
Scientific Analysis

5. Scientometrics Analysis of Nanotechnology in MEDLINE
Mohammad-Hossein Biglu*, Fatemeh Eskandari, Ali Asgharzadeh
Bioimpacts. 2011;1(3): 193-198. doi: 10.5681/bi.2011.027
PMCID: PMC3648963     PMID: 23678427     Scopus ID: 84876718392    
Article
PDF
XML
Cited By:
10
2
0
Editorial

6. Nanocosmetics: benefits and risks
Javad Shokri*
Bioimpacts. 2017;7(4): 207-208. doi: 10.15171/bi.2017.24
PMCID: PMC5801531     PMID: 29435427     Scopus ID: 85040988305    
Article
PDF
Full Text
XML
Cited By:
20
1
20

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge